NSB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NeuroScientific Biopharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 0.058 AUD -7.94% Market Closed

Market Cap: AU$22.6m

	NeuroScientific Biopharmaceuticals Ltd ASX:NSB	AU
P	Plus500 Ltd SWB:P55	IL
	Indah Kiat Pulp & Paper Tbk PT IDX:INKP	ID
B	Boston Beer Company Inc SWB:BBEA	US
P	Purefun Group AB (publ) F:DU3	SE
P	Philip Morris CR as XMUN:TBK	CZ
	China Everbright Water Ltd F:BIU2	CN

Profitability Summary

NeuroScientific Biopharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-712%

Negative 3Y Average Operating Margin

-394%

Declining Operating Margin

-21% > -712%

Negative Net Margin

-746%

Negative 3Y Average Net Margin

-400%

Declining Net Margin

-21% > -746%

Negative Free Cash Flow Margin

-441%

Negative 3Y Average Free Cash Flow Margin

-179%

Declining Free Cash Flow Margin

-46% > -441%

Negative ROE

-30%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-375%

Declining ROIC

115% > -45%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.